Colgate forecasts net sales to be roughly flat, while analysts had penciled in an increase of about 1%. The company expects organic sales growth to be within the 3% to 5

Consumer products company Colgate-Palmolive (NYSE:CL) in Q4 CY2024, with sales flat year on year at $4.94 billion. Its non-GAAP profit of $0.91 per share was 2.3% above analysts’ consensus estimates.

The Colgate-Palmolive stock price remains in a deep correction as investors wait for the fourth-quarter results. CL has plunged by over 17%, bringing its market cap to about $73 billion. So, is Colgate a good stock to buy the dip in?